Genetic Technologies Limited advised that Mr. Tony Di Pietro has provided his notice of resignation as Chief Financial Officer (CFO) of the Company. The Company has commenced a search for a new CFO with requisite dual ASX and Nasdaq listed company expertise. Mr. Di Pietro will remain in the role of CFO until a replacement commences with GTG or the end of March 2024, whichever date is the earliest.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | +4.35% | -14.29% | -11.11% |
Apr. 19 | Genetic Technologies Raising $2 Million via ADS Offering | MT |
Apr. 18 | Top Midday Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-11.11% | 10.35M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- GTG Stock
- News Genetic Technologies Limited
- Genetic Technologies Limited Announces Resignation of Tony Di Pietro as Chief Financial Officer